NuCana plc (NASDAQ:NCNA) Sees Significant Growth in Short InterestZolmax • 28 days ago
NuCana plc (NASDAQ:NCNA Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,480,000...
Share to Feed
In a report released today, Robyn Karnauskas from Truist Financial maintained a Buy rating on Nucana (NCNA Research Report). The company's shares...
NuCana shares are trading lower by 16.6% during Thursday's session. The company late Wednesday said it intends to adjust the ratio of its American Depository Shares (ADSs).
read more...
EDINBURGH, United Kingdom, March 27, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced plans to change the ratio of its American Depository Shares ( ADSs ) to its ordinary shares from...
NuCana plc (NASDAQ:NCNA Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,480,000...
NuCana plc (NASDAQ:NCNA Free Report) Stock analysts at William Blair issued their FY2024 EPS estimates for NuCana in a research note issued to investors on Thursday, March 21st...
Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Pipeline Continues to Advance with Key Data Readouts Expected for All Programs in 2024...
Gagnants
Le titre NuCana (NASDAQ:NCNA) a mont mercredi de 39,62% 0,54 dollars lors de la session ordinaire.
Le titre Kintara Therapeutics (NASDAQ:KTRA) a grimp de 36,96% 0,11 dollars.
L'action...
Titoli in rialzo
Le azioni di Kintara Therapeutics (NASDAQ:KTRA) hanno guadagnato il 39,27% a 0,12 dollari durante la sessione regolare di mercoled .
Il titolo NuCana (NASDAQ:NCNA) ha avuto un...